CXCR3 and myeloid sarcoma: Prior studies have separately demonstrated EBV-induced CXCR3 expression in B cells (48), positive correlation between CXCR3+ B cell frequencies and EBV viral load in people with MS (64), and T-bet+CXCR3+ B cell induction and neuroinvasion in people with MS (50).